These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 10580404

  • 1. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
    Cabrera C, Witvrouw M, Gutiérrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Esté JA.
    AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1535-43. PubMed ID: 10580404
    [Abstract] [Full Text] [Related]

  • 2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 20; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of anti-HIV activity of succinylated human serum albumin.
    Kuipers ME, vd Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, Huisman H.
    Biochem Pharmacol; 1999 Apr 15; 57(8):889-98. PubMed ID: 10086322
    [Abstract] [Full Text] [Related]

  • 6. Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins.
    Groenink M, Swart PJ, Broersen S, Kuipers M, Meijer DK, Schuitemaker H.
    AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):179-85. PubMed ID: 9007203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D, Esté JA, Cabrera C, De Clercq E.
    J Virol; 1998 May 20; 72(5):4032-7. PubMed ID: 9557691
    [Abstract] [Full Text] [Related]

  • 9. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ, Kuhmann SE, Morgan T, Herrera C, Rivera-Troche E, Xu S, Baroudy BM, Strizki J, Moore JP.
    Virology; 2005 Jul 20; 338(1):182-99. PubMed ID: 15935415
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
    Armand-Ugón M, Clotet-Codina I, Tintori C, Manetti F, Clotet B, Botta M, Esté JA.
    Virology; 2005 Dec 05; 343(1):141-9. PubMed ID: 16168454
    [Abstract] [Full Text] [Related]

  • 17. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    Cabrera C, Gutiérrez A, Blanco J, Barretina J, Litovchick A, Lapidot A, Evdokimov AG, Clotet B, Esté JA.
    AIDS Res Hum Retroviruses; 2000 May 01; 16(7):627-34. PubMed ID: 10791873
    [Abstract] [Full Text] [Related]

  • 18. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.
    Virology; 2005 Sep 01; 339(2):213-25. PubMed ID: 15996703
    [Abstract] [Full Text] [Related]

  • 19. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE, Stephen AG, Adelsberger JW, Roberts PE, Zhu W, Currens MJ, Feng Y, Crise BJ, Gorelick RJ, Rein AR, Fisher RJ, Shoemaker RH, Sei S.
    J Virol; 2005 May 01; 79(10):6122-33. PubMed ID: 15857997
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.
    Kuipers ME, Huisman JG, Swart PJ, de Béthune MP, Pauwels R, Schuitemaker H, De Clercq E, Meijer DK.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr 15; 11(5):419-29. PubMed ID: 8605586
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.